Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1030)	7/19/2005 3:30:02 PM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

NERX seems to have support at the 0.45 level. It has closed its July 6 upgap and needs to close above o.86 to try to climb back again above the $1 level.<g> It is up a moderate 6.9% on volume of 67.9Ks. bigcharts.marketwatch.com On July 11 was when it announced that it had treated the first patient with picoplatin, its next-generation intravenous platinum therapy,which is on a PII, open label, for small cell lung cancer. NERX has a good sized LTD and the insiders hold a good chunk of the shares.<g> It reportedly has around $0.45 in cash/shr. Bernard